Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Pharma

Pfizer's new Omicron-specific COVID booster to be available in Australia from next month

Another bivalent COVID-19 vaccine will be available to eligible Australians as a third and fourth booster, as case numbers climb.

ABC News

Experts rule out third COVID booster shot

Despite a spike in COVID-19 cases, the country's leading vaccine advisory body says Australians don't yet need a fifth dose of vaccine.

AAP

Staff at Consett chemical manufacturing company to strike in row over pay

Workers are set to strike for five days as they call for higher wages during the cost of living crisis

Chronicle Live

From analysis to the latest developments in health,
read the most diverse news in one place.

The COVID "Franken-virus" threat

A hybrid "Deltacron" strain could overtake BQ.1.1 as the most prevalent COVID strain. Here's what that would mean

Salon

Reunion Neuroscience Presents Q2 2023 Financial Results & Pipeline Update

Psychedelics biopharma company Reunion Neuroscience Inc. (NASDAQ: REUN) reported its business update and fiscal results for the second quarter ended September 30, 2022.

Benzinga

Unregulated 'innovation': India’s medicine problem

If India is the pharmacy of the world, it’s not doing a good job of providing safe products. A large number of children in the Gambia have recently died after ingesting cough syrup made in India. And in 2019, 11 children in India’s Jammu region died the same way. The…

The Conversation

Is Gilead Sciences Still a Buy Post COVID-19?

Gilead Sciences’ (GILD) popular covid product Veklury (Remdisivir) witnessed declining sales in the post-pandemic era. However, the company’s top line, excluding Veklury, has seen steady growth. Moreover, despite ongoing market volatility, the stock has registered stable gains. So, let’s find out if GILD is still a buy in the post-covid…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Bristol CBD company Amma Life promotes 'nature's gift' for wellness

It was one of the first CBD companies in the UK almost 10 years ago

Bristol Post

Hasbro, Ascendis Pharma, Coinbase Global And Some Other Big Stocks Moving Lower On Monday

U.S. stocks traded mixed, with the Nasdaq gaining more than 50 points on Monday. Here are some big stocks recording losses in today’s session.

Benzinga

Zynerba Pharmaceuticals R&D Expenses For Q3 Reach $5M, Here Are The Details

Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), released financial results for the third quarter ended September 30, 2022. Q3 2022 Financial Highlights

Benzinga

Disappointment after potential Alzheimer’s drug fails Roche trial

Swiss pharmaceutical firm carried out two identical phase 3 trials of gantenerumab, with about 1,000 volunteers in each

The Guardian - UK

Harry Kane-backed health food brand Bio&Me scores extra £1.6m investment

The company has deals with Asda, Boots, Holland & Barrett, Sainsbury’s, Tesco, the Co-op and Waitrose

Birmingham Post

A New Trial Will Allow NSW Pharmacies To Prescribe Some Medications Without Needing A GP Visit

Pharmacists can also administer a further six vaccines as of Monday.

Pedestrian.tv

Blow for people with Alzheimer's as 'promising' new Roche gantenerumab jab fails

The drug had held promise in earlier trials

Wales Online

Get all your
news in one place.

100's of premium titles.
One news app.

Manchester Evening News

As we head into a third winter battling Covid this is how the virus is affecting Greater Manchester now

Using the latest figures we attempt to assess how coronavirus is affecting Greater Manchester currently

Reuters

Uganda confirms Ebola case in country's east as outbreak expands

An Ebola case has been confirmed in Jinja in eastern Uganda, the country's health minister said on Sunday, the first time the outbreak has spread to a new region of the country from central Uganda where cases have been confined so far.

St. Louis Post-Dispatch

Why is a weedkiller showing up in Midwesterners’ urine?

St. LOUIS — A research group says levels of the controversial and drift-prone weedkiller dicamba have more than tripled in the urine samples of people in the Midwest — even in urban areas.

The Independent UK

Nine Covid symptoms affecting the fully vaccinated — and signs you may have it

Fainting and fatigue may signal onset of variant, experts say

Get all your
news in one place.

100's of premium titles.
One news app.

Glasgow Live

Glasgow doctor retires after saving millions of lives with new cancer vaccine

Professor Ian Frazer was one of the masterminds behind the development of the HPV vaccine against cervical cancer which continues to save thousands of lives each year

Inverse

Cannabis for pain: A scientist reveals how weed activates our body's opioid system

Marijuana may offer an alternative to pain management, as the compounds in cannabis activate the body's own opioid system, a neuropharmacologist explains.

Daily Record

Scots medic dubbed 'God's gift to women' retires after saving lives of millions

Professor Ian Frazer invented the HPV vaccine against cervical cancer which is saving thousands of lives every year

ABC News

Pharmaceutical giant Eli Lilly & Co apologises after fake Twitter account says insulin is free as Elon Musk rolls back verification

The incident is among a wave of impersonations that prompted Twitter to make its relaunched premium service unavailable.

Benzinga

A Look Into Bristol-Myers Squibb's Debt

Over the past three months, shares of Bristol-Myers Squibb Inc. (NYSE:BMY) rose by 2.13%. Before we understand the importance of debt, let's look at how much debt Bristol-Myers Squibb has.

The Independent UK

Pharmaceutical companies’ stocks dive after verified imposter Twitter account claims ‘insulin is free’

Insulin producers Eli Lilly, Novo Nordisk and Sanofi all reported losses during Friday’s trading

Irish Mirror

One Covid symptom is 'curiously' affecting mainly vaccinated people

While the jab is very effective at reducing your risk of serious illness, hospitalisation, and death, it does not guarantee you’ll avoid catching the virus altogether

1 … 102 103 104 105

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Office for National Statistics

UK Health Security Agency

509 stories

Lilly

356 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.